A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy Subjects

Clinical trial NCT02859259 · COMPLETED

Trial details

NCT number: NCT02859259
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2016-08-12
Primary completion: 2016-08-12
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.